Clinical trial
Using Behavioral Therapy in Combination With Darifenacin for Symptoms of…
NCT00127270 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00127270 |
|---|---|
| Title | Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder |
| Official title | Using Behavioral Therapy in Combination With Drug-Darifenacin for Symptoms of Overactive Bladder |
| Lead sponsor | Novartis, Industry |
| Collaborators | Procter and Gamble Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Urinary Incontinence |
| Intervention type | Behavioral, Drug |
| Interventions | Darifenacin, Behavioral therapy |
| Enrollment | 395 |
| Start date | May 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Aug 5, 2005 |
| Last update posted | Jan 24, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: